CN101663027A - 包含肠溶包衣的可促进药物释放的固体剂型 - Google Patents
包含肠溶包衣的可促进药物释放的固体剂型 Download PDFInfo
- Publication number
- CN101663027A CN101663027A CN200780052865A CN200780052865A CN101663027A CN 101663027 A CN101663027 A CN 101663027A CN 200780052865 A CN200780052865 A CN 200780052865A CN 200780052865 A CN200780052865 A CN 200780052865A CN 101663027 A CN101663027 A CN 101663027A
- Authority
- CN
- China
- Prior art keywords
- acid
- coating
- anionic
- outer coatings
- dosage forms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (72)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2007/054398 WO2008135090A1 (en) | 2007-05-07 | 2007-05-07 | Solid dosage forms comprising an enteric coating with accelerated drug release |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101663027A true CN101663027A (zh) | 2010-03-03 |
CN101663027B CN101663027B (zh) | 2013-02-27 |
Family
ID=39410284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007800528650A Active CN101663027B (zh) | 2007-05-07 | 2007-05-07 | 包含肠溶包衣的可促进药物释放的固体剂型 |
Country Status (19)
Country | Link |
---|---|
US (2) | US9597293B2 (zh) |
EP (1) | EP2152250B1 (zh) |
JP (1) | JP5167345B2 (zh) |
KR (1) | KR101443943B1 (zh) |
CN (1) | CN101663027B (zh) |
AU (1) | AU2007352872B2 (zh) |
BR (1) | BRPI0721654B8 (zh) |
CA (1) | CA2687130C (zh) |
CY (1) | CY1122582T1 (zh) |
DK (1) | DK2152250T3 (zh) |
ES (1) | ES2759626T3 (zh) |
HU (1) | HUE046488T2 (zh) |
IL (1) | IL201557A (zh) |
LT (1) | LT2152250T (zh) |
MX (1) | MX2009012030A (zh) |
PL (1) | PL2152250T3 (zh) |
PT (1) | PT2152250T (zh) |
SI (1) | SI2152250T1 (zh) |
WO (1) | WO2008135090A1 (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104125820A (zh) * | 2012-03-19 | 2014-10-29 | 富士施乐株式会社 | 片剂及其制造方法、片剂管理装置、片剂核对装置和程序 |
CN104271113A (zh) * | 2012-04-30 | 2015-01-07 | 狄洛特医药有限公司 | 延迟释放的药物制剂 |
CN104519876A (zh) * | 2012-08-27 | 2015-04-15 | 赢创工业集团股份有限公司 | 具有持续释放特征的和具有对乙醇影响的抗性的药物或保健品组合物 |
CN114269156A (zh) * | 2019-08-30 | 2022-04-01 | 陶氏环球技术有限责任公司 | 基于极性聚烯烃分散体的种子包衣组合物 |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
US8030350B2 (en) | 2005-02-24 | 2011-10-04 | Diffusion Pharmaceuticals Llc | Trans carotenoids, their synthesis, formulation and uses |
KR101570131B1 (ko) | 2007-04-13 | 2015-11-18 | 디퓨젼 파마슈티컬즈 엘엘씨 | 양극성 트랜스 카로티노이드의 말초혈관질환 치료와 예방을 위한 용도 |
PL2230932T3 (pl) | 2008-01-10 | 2017-09-29 | Evonik Röhm Gmbh | Powlekany preparat farmaceutyczny lub nutraceutyczny o zwiększonym uwalnianiu substancji aktywnej w jelicie grubym |
PE20141034A1 (es) | 2008-03-11 | 2014-09-10 | Takeda Pharmaceutical | Preparacion solida de desintegracion oral |
US10130689B2 (en) | 2009-06-22 | 2018-11-20 | Diffusion Pharmaceuticals Llc | Diffusion enhancing compounds and their use alone or with thrombolytics |
CA2801292C (en) * | 2010-06-02 | 2019-01-22 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
US10799460B2 (en) | 2011-09-07 | 2020-10-13 | Roland SAUR-BROSCH | Formulation for the controlled release of one or several substances in the digestive tract of a mammal |
WO2013076216A1 (en) | 2011-11-24 | 2013-05-30 | Synthon Bv | Controlled release particles comprising dimethyl fumarate |
CU24343B1 (es) * | 2012-04-30 | 2018-05-08 | Tillotts Pharma Ag | Formulación de fármaco de liberación retardada |
US20130295170A1 (en) * | 2012-05-03 | 2013-11-07 | Kydes Pharmaceuticals Llc | Compositions for control of drug abuse |
EP2916828A1 (en) * | 2012-11-07 | 2015-09-16 | Nazura Biohealth Inc. | Gras enteric coating formulations and methods of making and using same |
US8859005B2 (en) | 2012-12-03 | 2014-10-14 | Intercontinental Great Brands Llc | Enteric delivery of functional ingredients suitable for hot comestible applications |
LT2959892T (lt) * | 2013-02-22 | 2020-12-10 | Zeria Pharmaceutical Co., Ltd. | Enterine danga padengta tabletė |
WO2014136494A1 (ja) * | 2013-03-08 | 2014-09-12 | 富士フイルム株式会社 | 腸溶性細粒及び医薬組成物 |
BR122020013726B1 (pt) | 2013-10-29 | 2022-11-01 | Tillotts Pharma Ag | Formulação de droga de liberação retardada |
EP3236993B1 (en) | 2014-12-23 | 2023-09-13 | Theriva Biologics, Inc. | Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics |
US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11780848B2 (en) | 2015-10-16 | 2023-10-10 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof |
SG10201913987UA (en) | 2015-10-16 | 2020-03-30 | Abbvie Inc | PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF |
US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
JP7032320B2 (ja) | 2016-03-24 | 2022-03-08 | ディフュージョン・ファーマシューティカルズ・エルエルシー | 癌を処置するための、化学療法及び放射線療法を伴う二極性トランスカロテノイドの使用 |
EP3257501A1 (en) | 2016-06-14 | 2017-12-20 | Tillotts Pharma AG | Multiple unit dosage form comprising a core with individual core units covered by a mucoadhesive material, and an enteric core coating |
US11564922B2 (en) | 2017-03-09 | 2023-01-31 | Abbvie Inc. | Methods of treating crohn's disease and ulcerative colitis |
AU2018230500B2 (en) | 2017-03-09 | 2024-03-07 | Abbvie Inc. | Methods of treating Crohn's disease and ulcerative colitis |
US10524489B2 (en) * | 2017-07-12 | 2020-01-07 | Zinpro Corporation | Method and composition to control rumen release of cobalt to rumen bacteria for making vitamin B12 |
CA3072032A1 (en) | 2017-08-07 | 2019-02-14 | Finch Therapeutics, Inc. | Compositions and methods for maintaining and restoring a healthy gut barrier |
EP3737750B1 (en) | 2018-01-09 | 2024-06-05 | Theriva Biologics, Inc. | Alkaline phosphatase agents for treatment of neurodevelopmental disorders |
US12005086B2 (en) | 2018-02-23 | 2024-06-11 | Finch Therapeutics Holdings Llc | Microbiome related immunotherapies |
EP3773686B1 (en) | 2018-03-20 | 2023-06-07 | Theriva Biologics, Inc. | Alkaline phosphatase agents for treatment of radiation disorders |
EP3773513A4 (en) * | 2018-04-12 | 2022-05-18 | BPSI Holdings LLC | ACIDIFYING COATINGS AND WEATHER-RESISTANT SUBSTRATES COATED THEREOF |
EP3662901A1 (en) | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | Delayed release drug formulation comprising an outerlayer with an enzymaticyaaly degradable polymer, its composition and its method of manufacturing |
WO2020114616A1 (en) | 2018-12-07 | 2020-06-11 | Tillotts Pharma Ag | Topical treatment of immune checkpoint inhibitor induced diarrhoea, colitis or enterocolitis using antibodies and fragments thereof |
EP3662900A1 (en) | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | Colonic drug delivery formulation |
EP3662902A1 (en) | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | Colonic drug delivery formulation |
EP3662895A1 (en) | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | A process for manufacturing reducing sugar-free 5-asa tablet cores |
EP3662898A1 (en) | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | Solid composition comprising mesalazine |
BR112021022769A2 (pt) | 2019-05-15 | 2022-01-11 | Evonik Operations Gmbh | Processo para preparar cápsulas de invólucro duro cheias com revestimentos à base de copolímero de (met)acrilato com uma máquina de enchimento de cápsulas |
US20220331378A1 (en) | 2019-09-13 | 2022-10-20 | Finch Therapeutics Holdings Llc | Compositions and methods for treating autism spectrum disorder |
US20240131082A1 (en) | 2019-10-18 | 2024-04-25 | Finch Therapeutics Holdings Llc | Compositions and Methods for Delivering a Bacterial Metabolite to a Subject |
WO2021097288A1 (en) | 2019-11-15 | 2021-05-20 | Finch Therapeutics Holdings Llc | Compositions and methods for treating neurodegenerative diseases |
WO2021115648A1 (en) | 2019-12-11 | 2021-06-17 | Evonik Operations Gmbh | Dosage form comprising an alkaline agent and an enteric coating layer |
US11730708B2 (en) | 2019-12-11 | 2023-08-22 | Evonik Operations Gmbh | Dosage form for use in treating or preventing of a disease |
JP2023505883A (ja) | 2019-12-11 | 2023-02-13 | エボニック オペレーションズ ゲーエムベーハー | 病気の治療又は予防において使用するための剤形 |
WO2021142358A1 (en) | 2020-01-10 | 2021-07-15 | Finch Therapeutics Holdings Llc | Compositions and methods for treating hepatic encephalopathy (he) |
WO2021142347A1 (en) | 2020-01-10 | 2021-07-15 | Finch Therapeutics Holdings Llc | Compositions and methods for non-alcoholic steatohepatitis (nash) |
WO2021142353A1 (en) | 2020-01-10 | 2021-07-15 | Finch Therapeutics Holdings Llc | Compositions and methods for treating hepatitis b (hbv) and hepatitis d (hdv) |
WO2021202806A1 (en) | 2020-03-31 | 2021-10-07 | Finch Therapeutics Holdings Llc | Compositions comprising non-viable fecal microbiota and methods of use thereof |
WO2022178294A1 (en) | 2021-02-19 | 2022-08-25 | Finch Therapeutics Holdings Llc | Compositions and methods for providing secondary bile acids to a subject |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58135807A (ja) * | 1982-02-05 | 1983-08-12 | Shin Etsu Chem Co Ltd | 腸溶性被覆薬剤の製造方法 |
DE3208791A1 (de) * | 1982-03-11 | 1983-09-22 | Röhm GmbH, 6100 Darmstadt | Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
IT1246382B (it) | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
US5188836A (en) * | 1990-07-27 | 1993-02-23 | Warner-Lambert Company | Sustained release formulations |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
SE9500478D0 (sv) | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
SE9600071D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
US6623759B2 (en) | 1996-06-28 | 2003-09-23 | Astrazeneca Ab | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
DE19626045C2 (de) * | 1996-06-28 | 1998-12-03 | Klinge Co Chem Pharm Fab | Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben |
US6312728B1 (en) * | 1998-07-07 | 2001-11-06 | Cascade Development, Inc. | Sustained release pharmaceutical preparation |
CA2359812C (en) * | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
HU229291B1 (en) | 2001-01-31 | 2013-10-28 | Evonik Roehm Gmbh | Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
OA12624A (en) * | 2001-06-22 | 2006-06-12 | Pfizer Prod Inc | Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers. |
CA2444814C (en) | 2001-10-24 | 2009-06-09 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
MXPA04004747A (es) * | 2001-11-23 | 2004-08-02 | Procter & Gamble | Forma de dosificacion farmaceutica con multiples recubrimientos. |
US20060183186A1 (en) * | 2001-12-21 | 2006-08-17 | Koh Sang S | Gene expression profiles in stomach cancer |
DE10208335A1 (de) * | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Arzneiform und Verfahren zu ihrer Herstellung |
EP1526843A1 (en) * | 2002-07-25 | 2005-05-04 | Pharmacia Corporation | Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former |
US20040028737A1 (en) | 2002-08-12 | 2004-02-12 | Kopran Research Laboratories Limited | Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same |
DK1648421T3 (en) * | 2003-07-24 | 2017-12-04 | Glaxosmithkline Llc | ORAL SOLUBLE MOVIES |
JP4277904B2 (ja) | 2004-04-30 | 2009-06-10 | アステラス製薬株式会社 | 経口投与用時限放出型粒子状医薬組成物及び該組成物を含有する口腔内速崩壊錠 |
WO2006042277A2 (en) | 2004-10-12 | 2006-04-20 | Eisai R&D Management Co., Ltd. | Extended release compositions of proton pump inhibitors |
DE102005007059A1 (de) | 2005-02-15 | 2006-08-24 | Röhm GmbH & Co. KG | Teilneutralisiertes anionisches (Meth)acrylat-Copolymer |
US9149439B2 (en) * | 2005-03-21 | 2015-10-06 | Sandoz Ag | Multi-particulate, modified-release composition |
DE102005032806A1 (de) * | 2005-07-12 | 2007-01-18 | Röhm Gmbh | Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten |
DE102006035549A1 (de) | 2006-07-27 | 2008-01-31 | Evonik Röhm Gmbh | Arzneiform mit mindestens zweischichtiger Trennschicht |
PL2051704T3 (pl) | 2006-08-18 | 2012-09-28 | Evonik Roehm Gmbh | Kompozycja farmaceutyczna o kontrolowanym dostarczaniu substancji aktywnej o dobrej rozpuszczalności |
PL2230932T3 (pl) | 2008-01-10 | 2017-09-29 | Evonik Röhm Gmbh | Powlekany preparat farmaceutyczny lub nutraceutyczny o zwiększonym uwalnianiu substancji aktywnej w jelicie grubym |
-
2007
- 2007-05-07 KR KR1020097023249A patent/KR101443943B1/ko active IP Right Grant
- 2007-05-07 PT PT77288512T patent/PT2152250T/pt unknown
- 2007-05-07 JP JP2010506808A patent/JP5167345B2/ja active Active
- 2007-05-07 DK DK07728851T patent/DK2152250T3/da active
- 2007-05-07 HU HUE07728851A patent/HUE046488T2/hu unknown
- 2007-05-07 WO PCT/EP2007/054398 patent/WO2008135090A1/en active Application Filing
- 2007-05-07 BR BRPI0721654A patent/BRPI0721654B8/pt active IP Right Grant
- 2007-05-07 CN CN2007800528650A patent/CN101663027B/zh active Active
- 2007-05-07 US US12/598,138 patent/US9597293B2/en active Active
- 2007-05-07 LT LTEP07728851.2T patent/LT2152250T/lt unknown
- 2007-05-07 SI SI200732140T patent/SI2152250T1/sl unknown
- 2007-05-07 CA CA2687130A patent/CA2687130C/en active Active
- 2007-05-07 ES ES07728851T patent/ES2759626T3/es active Active
- 2007-05-07 AU AU2007352872A patent/AU2007352872B2/en active Active
- 2007-05-07 PL PL07728851T patent/PL2152250T3/pl unknown
- 2007-05-07 MX MX2009012030A patent/MX2009012030A/es active IP Right Grant
- 2007-05-07 EP EP07728851.2A patent/EP2152250B1/en active Active
-
2009
- 2009-10-15 IL IL201557A patent/IL201557A/en active IP Right Grant
-
2012
- 2012-09-05 US US13/603,984 patent/US10537530B2/en active Active
-
2019
- 2019-12-04 CY CY20191101282T patent/CY1122582T1/el unknown
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10074170B2 (en) | 2012-03-19 | 2018-09-11 | Fuji Xerox Co., Ltd. | Method of producing tablet comprising specific exhausted air relative humidity |
US11308607B2 (en) | 2012-03-19 | 2022-04-19 | FUJIFILM Business Innovation Corn. | Tablet having uniquely identifiable shape, tablet verification device and program |
CN104125820A (zh) * | 2012-03-19 | 2014-10-29 | 富士施乐株式会社 | 片剂及其制造方法、片剂管理装置、片剂核对装置和程序 |
CN110200949A (zh) * | 2012-04-30 | 2019-09-06 | 狄洛特医药有限公司 | 延迟释放的药物制剂 |
CN106983735A (zh) * | 2012-04-30 | 2017-07-28 | 狄洛特医药有限公司 | 延迟释放的药物制剂 |
TWI618547B (zh) * | 2012-04-30 | 2018-03-21 | 迪洛特醫藥有限公司 | 緩釋藥物配方 |
CN104271113B (zh) * | 2012-04-30 | 2019-03-22 | 狄洛特医药有限公司 | 延迟释放的药物制剂 |
CN104302274A (zh) * | 2012-04-30 | 2015-01-21 | 狄洛特医药有限公司 | 延迟释放的药物制剂 |
CN110237056A (zh) * | 2012-04-30 | 2019-09-17 | 狄洛特医药有限公司 | 延迟释放的药物制剂 |
CN110200949B (zh) * | 2012-04-30 | 2021-11-16 | 狄洛特医药有限公司 | 延迟释放的药物制剂 |
CN110237056B (zh) * | 2012-04-30 | 2022-03-08 | 狄洛特医药有限公司 | 延迟释放的药物制剂 |
CN104271113A (zh) * | 2012-04-30 | 2015-01-07 | 狄洛特医药有限公司 | 延迟释放的药物制剂 |
CN104519876A (zh) * | 2012-08-27 | 2015-04-15 | 赢创工业集团股份有限公司 | 具有持续释放特征的和具有对乙醇影响的抗性的药物或保健品组合物 |
US10842752B2 (en) | 2012-08-27 | 2020-11-24 | Evonik Operations Gmbh | Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol |
CN114269156A (zh) * | 2019-08-30 | 2022-04-01 | 陶氏环球技术有限责任公司 | 基于极性聚烯烃分散体的种子包衣组合物 |
CN114269156B (zh) * | 2019-08-30 | 2024-05-31 | 陶氏环球技术有限责任公司 | 基于极性聚烯烃分散体的种子包衣组合物 |
Also Published As
Publication number | Publication date |
---|---|
KR20100016306A (ko) | 2010-02-12 |
HUE046488T2 (hu) | 2020-03-30 |
DK2152250T3 (da) | 2019-12-09 |
WO2008135090A8 (en) | 2009-03-05 |
IL201557A0 (en) | 2010-05-31 |
PT2152250T (pt) | 2019-12-12 |
CA2687130C (en) | 2017-10-03 |
JP5167345B2 (ja) | 2013-03-21 |
BRPI0721654A2 (pt) | 2013-01-29 |
IL201557A (en) | 2017-06-29 |
US10537530B2 (en) | 2020-01-21 |
BRPI0721654B8 (pt) | 2022-07-05 |
JP2010526110A (ja) | 2010-07-29 |
ES2759626T3 (es) | 2020-05-11 |
PL2152250T3 (pl) | 2020-06-15 |
CY1122582T1 (el) | 2021-01-27 |
CN101663027B (zh) | 2013-02-27 |
SI2152250T1 (sl) | 2020-06-30 |
BRPI0721654B1 (pt) | 2019-10-22 |
US20130058986A1 (en) | 2013-03-07 |
AU2007352872B2 (en) | 2013-03-14 |
KR101443943B1 (ko) | 2014-10-07 |
MX2009012030A (es) | 2010-01-25 |
EP2152250A1 (en) | 2010-02-17 |
CA2687130A1 (en) | 2008-11-13 |
EP2152250B1 (en) | 2019-09-04 |
US9597293B2 (en) | 2017-03-21 |
AU2007352872A1 (en) | 2008-11-13 |
US20100129446A1 (en) | 2010-05-27 |
WO2008135090A1 (en) | 2008-11-13 |
LT2152250T (lt) | 2019-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101663027B (zh) | 包含肠溶包衣的可促进药物释放的固体剂型 | |
CA2570608C (en) | Multiparticle pharmaceutical form for low-solubility active substances and a process for preparing the pharmaceutical form | |
CA2478506C (en) | Pharmaceutical formulation for the active ingredient budesonide | |
JP5582701B2 (ja) | 被覆医薬製剤およびポリマー混合被覆した医薬製剤の製造のためのポリマー混合物の使用 | |
KR101454056B1 (ko) | 에탄올의 영향에 대하여 내성을 가지는 비-오피오이드용 ph-의존성 조절 방출 제약 조성물 | |
JP4436475B2 (ja) | 固体の経口用薬剤形のための結合剤または被覆の製造に適当な水性分散液、該水性分散液の使用および再分散性粉末 | |
JPH07252140A (ja) | 持続性放出被覆を有する不溶性医薬品の即時放出錠剤コア | |
JP2005516020A (ja) | ゼロ次持続放出剤形およびその製造方法 | |
JP2007070363A (ja) | 持続性放出被覆を有する不溶性医薬品の即時放出錠剤コア | |
CA2609439A1 (en) | Use of a partially neutralized, anionic (meth)acrylate copolymer as a coating for the production of a pharmaceutical form releasing active substance at reduced ph values | |
BR112013003581B1 (pt) | Composição farmacêutica ou nutracêutica gastro resistente, que compreende um ou mais sais do ácido algínico, e seu processo de produção | |
IL185218A (en) | An anionic copolymer of (dead) acrylate is partially contradictory | |
ZA200101485B (en) | Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same. | |
US20030175342A1 (en) | Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate | |
Thoma et al. | Enteric coated hard gelatin capsules | |
JP7021108B2 (ja) | ニコチンアミドの経口薬学的組成物 | |
JP2001192344A (ja) | フィルムコーティング剤及び経口固形製剤 | |
NZ718686A (en) | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | |
Naiserová et al. | perorálních tablet | |
NZ718686B2 (en) | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Darmstadt Patentee after: Roma Chemical Co.,Ltd. Address before: Darmstadt Patentee before: EVONIK ROHM GmbH Address after: Essen, Germany Patentee after: Evonik Operations Ltd. Address before: Essen, Germany Patentee before: EVONIK DEGUSSA GmbH |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200622 Address after: Essen, Germany Patentee after: EVONIK DEGUSSA GmbH Address before: Darmstadt Patentee before: Roma Chemical Co.,Ltd. |